Skip to main content
Erschienen in: Digestive Diseases and Sciences 6/2018

29.03.2018 | Original Article

Hispanic Americans and Non-Hispanic White Americans Have a Similar Inflammatory Bowel Disease Phenotype: A Systematic Review with Meta-Analysis

verfasst von: Danny J. Avalos, Antonio Mendoza-Ladd, Marc J. Zuckerman, Mohammad Bashashati, Andres Alvarado, Alok Dwivedi, Oriana M. Damas

Erschienen in: Digestive Diseases and Sciences | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Inflammatory bowel disease (IBD) is a devastating immune-mediated disease on the rise in Hispanics living in the USA. Prior observational studies comparing IBD characteristics between Hispanics and non-Hispanic whites (NHW) have yielded mixed results.

Aims

We performed a meta-analysis of observational studies examining IBD phenotype in Hispanics compared to NHW.

Methods

We conducted a systematic search of US-based studies comparing IBD subtype (Ulcerative Colitis: UC or Crohn’s disease: CD) and phenotype (disease location and behavior) between Hispanics and NHW. We evaluated differences in age at IBD diagnosis, the presence of family history and smoking history. A random effects model was chosen “a priori.” Categorical and continuous variables were analyzed using odds ratio (OR) or standard mean difference (SMD), respectively.

Results

Seven studies were included with 687 Hispanics and 1586 NHW. UC was more common in Hispanics compared to NHW (OR 2.07, CI 1.13–3.79, p = 0.02). Location of disease was similar between Hispanics and NHW except for the presence of upper gastrointestinal CD, which was less common in Hispanics (OR 0.58, CI 0.32–1.06, p = 0.07). Hispanics were less likely to smoke (OR 0.48, CI 0.26–0.89, p = 0.02) or have a family history of IBD (OR 0.35, CI 0.22–0.55, p < 0.001). CD behavior classified by Montreal classification and age at IBD diagnosis were similar between Hispanics and NHW.

Conclusion

UC was more common among US Hispanics compared to NHW. Age at IBD diagnosis is similar for both Hispanics and NHW. For CD, disease behavior is similar, but Hispanics show a trend for less upper gastrointestinal involvement. A family history of IBD and smoking history were less common in Hispanics.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017;152(313–321):e312. Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017;152(313–321):e312.
2.
Zurück zum Zitat Ng SC, Bernstein CN, Vatn MH, et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62:630–649.CrossRefPubMed Ng SC, Bernstein CN, Vatn MH, et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62:630–649.CrossRefPubMed
3.
Zurück zum Zitat Dahlhamer JM, Zammitti EP, Ward BW, et al. Prevalence of inflammatory bowel disease among adults aged >/=18 years—United States, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:1166–1169.CrossRefPubMed Dahlhamer JM, Zammitti EP, Ward BW, et al. Prevalence of inflammatory bowel disease among adults aged >/=18 years—United States, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:1166–1169.CrossRefPubMed
4.
Zurück zum Zitat Bosques-Padilla FJ, Sandoval-Garcia ER, Martinez-Vazquez MA, et al. Epidemiology and clinical characteristics of ulcerative colitis in north-eastern Mexico. Rev Gastroenterol Mex. 2011;76:34–38.PubMed Bosques-Padilla FJ, Sandoval-Garcia ER, Martinez-Vazquez MA, et al. Epidemiology and clinical characteristics of ulcerative colitis in north-eastern Mexico. Rev Gastroenterol Mex. 2011;76:34–38.PubMed
5.
Zurück zum Zitat Farrukh A, Mayberry JF. Inflammatory bowel disease in Hispanic communities: a concerted South American approach could identify the aetiology of Crohn’s disease and ulcerative colitis. Arq Gastroenterol. 2014;51:271–275.CrossRefPubMed Farrukh A, Mayberry JF. Inflammatory bowel disease in Hispanic communities: a concerted South American approach could identify the aetiology of Crohn’s disease and ulcerative colitis. Arq Gastroenterol. 2014;51:271–275.CrossRefPubMed
6.
Zurück zum Zitat Mendoza Ladd A, Jia Y, Yu C, et al. Demographic and clinical characteristics of a predominantly hispanic population with inflammatory bowel disease on the US-Mexico border. South Med J.. 2016;109:792–797.PubMed Mendoza Ladd A, Jia Y, Yu C, et al. Demographic and clinical characteristics of a predominantly hispanic population with inflammatory bowel disease on the US-Mexico border. South Med J.. 2016;109:792–797.PubMed
7.
Zurück zum Zitat Downes MJ, Brennan ML, Williams HC, et al. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open. 2016;6:e011458.CrossRefPubMedPubMedCentral Downes MJ, Brennan ML, Williams HC, et al. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open. 2016;6:e011458.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–2012.CrossRefPubMed Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–2012.CrossRefPubMed
9.
Zurück zum Zitat Basu D, Lopez I, Kulkarni A, et al. Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol. 2005;100:2254–2261.CrossRefPubMed Basu D, Lopez I, Kulkarni A, et al. Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol. 2005;100:2254–2261.CrossRefPubMed
10.
Zurück zum Zitat Damas OM, Jahann DA, Reznik R, et al. Phenotypic manifestations of inflammatory bowel disease differ between Hispanics and non-Hispanic whites: results of a large cohort study. Am J Gastroenterol. 2013;108:231–239.CrossRefPubMed Damas OM, Jahann DA, Reznik R, et al. Phenotypic manifestations of inflammatory bowel disease differ between Hispanics and non-Hispanic whites: results of a large cohort study. Am J Gastroenterol. 2013;108:231–239.CrossRefPubMed
11.
Zurück zum Zitat Hou J, El-Serag H, Sellin J, et al. Inflammatory bowel disease characteristics and treatment in Hispanics and Caucasians. Dig Dis Sci. 2011;56:1476–1481.CrossRefPubMed Hou J, El-Serag H, Sellin J, et al. Inflammatory bowel disease characteristics and treatment in Hispanics and Caucasians. Dig Dis Sci. 2011;56:1476–1481.CrossRefPubMed
12.
Zurück zum Zitat Mannino C, Malin J, Conn AR, et al. Racial/ethnic differences in inflammatory bowel disease phenotypes at a tertiary care academic medical center. Gastroenterology. 2013;144:S389.CrossRef Mannino C, Malin J, Conn AR, et al. Racial/ethnic differences in inflammatory bowel disease phenotypes at a tertiary care academic medical center. Gastroenterology. 2013;144:S389.CrossRef
13.
Zurück zum Zitat Nguyen GC, Torres EA, Regueiro M, et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006;101:1012–1023.CrossRefPubMed Nguyen GC, Torres EA, Regueiro M, et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006;101:1012–1023.CrossRefPubMed
14.
15.
Zurück zum Zitat Betteridge JD, Armbruster SP, Maydonovitch C, et al. Inflammatory bowel disease prevalence by age, gender, race, and geographic location in the U.S. military health care population. Inflamm Bowel Dis. 2013;19:1421–1427.CrossRefPubMed Betteridge JD, Armbruster SP, Maydonovitch C, et al. Inflammatory bowel disease prevalence by age, gender, race, and geographic location in the U.S. military health care population. Inflamm Bowel Dis. 2013;19:1421–1427.CrossRefPubMed
16.
Zurück zum Zitat Nguyen GC, Chong CA, Chong RY. National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States. J Crohns Colitis. 2014;8:288–295.CrossRefPubMed Nguyen GC, Chong CA, Chong RY. National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States. J Crohns Colitis. 2014;8:288–295.CrossRefPubMed
17.
Zurück zum Zitat Kim HJ, Hann HJ, Hong SN, et al. Incidence and natural course of inflammatory bowel disease in Korea, 2006–2012: a nationwide population-based study. Inflamm Bowel Dis. 2015;21:623–630.CrossRefPubMed Kim HJ, Hann HJ, Hong SN, et al. Incidence and natural course of inflammatory bowel disease in Korea, 2006–2012: a nationwide population-based study. Inflamm Bowel Dis. 2015;21:623–630.CrossRefPubMed
18.
Zurück zum Zitat Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study. Gastroenterology. 2013;145(158–165):e152. Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study. Gastroenterology. 2013;145(158–165):e152.
19.
Zurück zum Zitat Wei SC, Lin MH, Tung CC, et al. A nationwide population-based study of the inflammatory bowel diseases between 1998 and 2008 in Taiwan. BMC Gastroenterol. 2013;13:166.CrossRefPubMedPubMedCentral Wei SC, Lin MH, Tung CC, et al. A nationwide population-based study of the inflammatory bowel diseases between 1998 and 2008 in Taiwan. BMC Gastroenterol. 2013;13:166.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Juliao F, Marquez J, Aristizabal N, et al. Clinical efficacy of infliximab in moderate to severe ulcerative colitis in a latin american referral population. Digestion. 2013;88:222–228.CrossRefPubMed Juliao F, Marquez J, Aristizabal N, et al. Clinical efficacy of infliximab in moderate to severe ulcerative colitis in a latin american referral population. Digestion. 2013;88:222–228.CrossRefPubMed
21.
Zurück zum Zitat Paredes Mendez J, Moreno Otoya, Mestanza Rivas Plata AL, et al. Epidemiological and clinical characteristics of inflammatory bowel disease in a tertiary referral hospital in Lima-Peru. Rev Gastroenterol Peru. 2016;36:209–218.PubMed Paredes Mendez J, Moreno Otoya, Mestanza Rivas Plata AL, et al. Epidemiological and clinical characteristics of inflammatory bowel disease in a tertiary referral hospital in Lima-Peru. Rev Gastroenterol Peru. 2016;36:209–218.PubMed
22.
Zurück zum Zitat Simian D, Fluxa D, Flores L, et al. Inflammatory bowel disease: a descriptive study of 716 local Chilean patients. World J Gastroenterol. 2016;22:5267–5275.CrossRefPubMedPubMedCentral Simian D, Fluxa D, Flores L, et al. Inflammatory bowel disease: a descriptive study of 716 local Chilean patients. World J Gastroenterol. 2016;22:5267–5275.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Yamamoto-Furusho JK. Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987–2006). J Clin Gastroenterol. 2009;43:221–224.CrossRefPubMed Yamamoto-Furusho JK. Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987–2006). J Clin Gastroenterol. 2009;43:221–224.CrossRefPubMed
24.
Zurück zum Zitat Torres EA, Cruz A, Monagas M, et al. Inflammatory bowel disease in Hispanics: The University of Puerto Rico IBD registry. Int J Inflamm. 2012;2012:574079.CrossRef Torres EA, Cruz A, Monagas M, et al. Inflammatory bowel disease in Hispanics: The University of Puerto Rico IBD registry. Int J Inflamm. 2012;2012:574079.CrossRef
25.
Zurück zum Zitat Baños FJ, Ruiz Vélez MH, Flórez Arango JF. Phenotypes and natural history of Inflammatory Bowel Disease (IBD) in a referral population in Medellín, Colombia. Revista Colombiana de Gastroenterología. 2010;25:240–251. Baños FJ, Ruiz Vélez MH, Flórez Arango JF. Phenotypes and natural history of Inflammatory Bowel Disease (IBD) in a referral population in Medellín, Colombia. Revista Colombiana de Gastroenterología. 2010;25:240–251.
26.
Zurück zum Zitat Damas OM, Avalos DJ, Palacio AM, et al. Inflammatory bowel disease is presenting sooner after immigration in more recent US immigrants from Cuba. Aliment Pharmacol Ther. 2017;46:303–309.CrossRefPubMedPubMedCentral Damas OM, Avalos DJ, Palacio AM, et al. Inflammatory bowel disease is presenting sooner after immigration in more recent US immigrants from Cuba. Aliment Pharmacol Ther. 2017;46:303–309.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Shivashankar R, Tremaine WJ, Harmsen WS, et al. Incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010. Clin Gastroenterol Hepatol. 2017;15:857–863.CrossRefPubMed Shivashankar R, Tremaine WJ, Harmsen WS, et al. Incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010. Clin Gastroenterol Hepatol. 2017;15:857–863.CrossRefPubMed
28.
Zurück zum Zitat Parente JM, Coy CS, Campelo V, et al. Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil. World J Gastroenterol. 2015;21:1197–1206.CrossRefPubMedPubMedCentral Parente JM, Coy CS, Campelo V, et al. Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil. World J Gastroenterol. 2015;21:1197–1206.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Garcia-Subirats I, Vargas I, Mogollon-Perez AS, et al. Inequities in access to health care in different health systems: a study in municipalities of central Colombia and north-eastern Brazil. Int J Equity Health. 2014;13:10.CrossRefPubMedPubMedCentral Garcia-Subirats I, Vargas I, Mogollon-Perez AS, et al. Inequities in access to health care in different health systems: a study in municipalities of central Colombia and north-eastern Brazil. Int J Equity Health. 2014;13:10.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Vazquez ML, Vargas I, Garcia-Subirats I, et al. Doctors’ experience of coordination across care levels and associated factors. A cross-sectional study in public healthcare networks of six Latin American countries. Soc Sci Med. 2017;182:10–19.CrossRefPubMed Vazquez ML, Vargas I, Garcia-Subirats I, et al. Doctors’ experience of coordination across care levels and associated factors. A cross-sectional study in public healthcare networks of six Latin American countries. Soc Sci Med. 2017;182:10–19.CrossRefPubMed
32.
Zurück zum Zitat Morgan BW, Leifheit KM, Romero KM, et al. Low cigarette smoking prevalence in peri-urban Peru: results from a population-based study of tobacco use by self-report and urine cotinine. Tob Induc Dis. 2017;15:32.CrossRefPubMedPubMedCentral Morgan BW, Leifheit KM, Romero KM, et al. Low cigarette smoking prevalence in peri-urban Peru: results from a population-based study of tobacco use by self-report and urine cotinine. Tob Induc Dis. 2017;15:32.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Weygandt PL, Vidal-Cardenas E, Gilman RH, et al. Epidemiology of tobacco use and dependence in adults in a poor peri-urban community in Lima, Peru. BMC Pulm Med. 2012;12:9.CrossRefPubMedPubMedCentral Weygandt PL, Vidal-Cardenas E, Gilman RH, et al. Epidemiology of tobacco use and dependence in adults in a poor peri-urban community in Lima, Peru. BMC Pulm Med. 2012;12:9.CrossRefPubMedPubMedCentral
Metadaten
Titel
Hispanic Americans and Non-Hispanic White Americans Have a Similar Inflammatory Bowel Disease Phenotype: A Systematic Review with Meta-Analysis
verfasst von
Danny J. Avalos
Antonio Mendoza-Ladd
Marc J. Zuckerman
Mohammad Bashashati
Andres Alvarado
Alok Dwivedi
Oriana M. Damas
Publikationsdatum
29.03.2018
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 6/2018
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5022-7

Weitere Artikel der Ausgabe 6/2018

Digestive Diseases and Sciences 6/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.